Efficacy of human intravenous immune globulin in pyoderma gangrenosum

Journal of the American Academy of Dermatology

Volumn 32, Issue 1, 1995, Pages 140-142

  Gupta, Aditya K ^a,b   Shear, Neil H ^a,b   Sauder, Daniel N ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INSECT BITE; INTRALESIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN ULCER; TOPICAL DRUG ADMINISTRATION;

ADULT; CASE REPORT; FEMALE; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

EID: 0028813894     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(95)90218-X     Document Type: Article

References (30)

1. Pyoderma gangrenosum clinical and experimental observations in five cases occurring in adults
2. Pyoderma gangrenosum and related disorders
3. Hypogammaglobulinemia in pyoderma gangrenosum
4. Pyoderma gangrenosum secondary to insect bite
5. Pyoderma gangrenosum associated with hypogammaglobulinemia
6. Pyoderma gangrenosum complicating a simple skin graft
7. Pyoderma gangrenosum controlled by cortisone: report of a case
8. Pyoderma gangrenosum with and without hypogammaglobulinemia
9. Pyoderma gangrenosum
10. Pyoderma gangrenosum treated with 6-mercaptopurine and followed by acute leukemia
11. Chronic pyoderma
12. Pyoderma gangrenosum, peptic ulcer and a $625,000 damage award
13. Pyoderma and dysgammaglobulinemia
14. Primary acquired hypogammaglobulinemia, diabetes mellitus, recurrent pyoderma, and obesity
15. Pyoderma gangrenosum au cours d'une hypogammaglobulinemie congenitale
16. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids
17. Use of intravenous immune globulin therapy: an overview
18. Agammaglobulinemia
19. Uses of intravenous globulin to prevent or treat infections
20. Use of intravenous gammaglobulin as an immune replacement and an immune suppressant
21. Immunoglobulin G dimer: an idiotype-anti-idiotype complex
22. High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses
23. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients
24. Treatment of dermatomyositis with intravenous gammaglobulin
25. In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanism
26. Recent progress in the use of intravenous immunoglobulin
27. The uses of intravenous immune globulin in collagen vascular disorders
28. Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease
29. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders
30. Treatment of systemic vasculitis with pooled intravenous immunoglobulin